# PureTech Health plc: financial statements, quarterly

PTCHF · OTC · CIK 1782999 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ptchf.md) · [Financials](/companies/ptchf/financials.md) · [Filings](/companies/ptchf/filings.md) · [Insiders](/companies/ptchf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ptchf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [72.6](/filings/0001628280-21-006938.md) | [117](/filings/0001782999-22-000004.md) | [132](/filings/0001782999-23-000004.md) | [404](/filings/0001628280-24-017913.md) | [466](/filings/0001782999-25-000005.md) | [150](/filings/0001782999-25-000005.md) | [191](/filings/0001782999-25-000005.md) | [281](/filings/0001782999-25-000005.md) |
| Current assets | $m | not reported | not reported | [169](/filings/0001628280-21-006938.md) | [414](/filings/0001782999-22-000004.md) | [502](/filings/0001782999-23-000004.md) | [386](/filings/0001628280-24-017913.md) | [347](/filings/0001782999-25-000005.md) | [386](/filings/0001782999-25-000005.md) |
| Total assets | $m | not reported | not reported | [941](/filings/0001628280-21-006938.md) | [990](/filings/0001782999-22-000004.md) | [946](/filings/0001782999-23-000004.md) | [703](/filings/0001628280-24-017913.md) | [694](/filings/0001782999-25-000005.md) | [603](/filings/0001782999-25-000005.md) |
| Current liabilities | $m | not reported | not reported | [139](/filings/0001628280-21-006938.md) | [181](/filings/0001782999-22-000004.md) | [226](/filings/0001782999-23-000004.md) | [96.9](/filings/0001628280-24-017913.md) | [51.4](/filings/0001782999-25-000005.md) | [41.4](/filings/0001782999-25-000005.md) |
| Total liabilities | $m | not reported | not reported | [291](/filings/0001628280-21-006938.md) | [336](/filings/0001782999-22-000004.md) | [362](/filings/0001782999-23-000004.md) | [155](/filings/0001628280-24-017913.md) | [236](/filings/0001782999-25-000005.md) | [195](/filings/0001782999-25-000005.md) |
| Shareholders' equity | $m | [71.8](/filings/0001628280-21-006938.md) | [168](/filings/0001782999-22-000004.md) | [668](/filings/0001628280-21-006938.md) | [670](/filings/0001782999-22-000004.md) | [594](/filings/0001782999-23-000004.md) | [542](/filings/0001628280-24-017913.md) | [464](/filings/0001782999-25-000005.md) | [415](/filings/0001782999-25-000005.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 241,684,038 at 2025-12-31, from the cover of the [20-F filed 2026-04-29](/filings/0001628280-26-028200.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.